- Home
- STNE vs ARWR Comparison
STNE vs ARWR Comparison
Compare STNE & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STNE
- ARWR
- Stock Information
- Founded
- STNE 2012
- ARWR 2003
- Country
- STNE Cayman Islands
- ARWR United States
- Employees
- STNE N/A
- ARWR N/A
- Industry
- STNE EDP Services
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- STNE Technology
- ARWR Health Care
- Exchange
- STNE Nasdaq
- ARWR Nasdaq
- Market Cap
- STNE 5.0B
- ARWR 5.6B
- IPO Year
- STNE 2018
- ARWR 1993
- Fundamental
- Price
- STNE $16.07
- ARWR $40.91
- Analyst Decision
- STNE Buy
- ARWR Buy
- Analyst Count
- STNE 8
- ARWR 9
- Target Price
- STNE $17.44
- ARWR $47.44
- AVG Volume (30 Days)
- STNE 5.7M
- ARWR 1.7M
- Earning Date
- STNE 11-06-2025
- ARWR 11-25-2025
- Dividend Yield
- STNE N/A
- ARWR N/A
- EPS Growth
- STNE N/A
- ARWR N/A
- EPS
- STNE N/A
- ARWR N/A
- Revenue
- STNE $2,670,485,228.00
- ARWR $572,976,000.00
- Revenue This Year
- STNE $17.20
- ARWR $21,287.22
- Revenue Next Year
- STNE $7.55
- ARWR N/A
- P/E Ratio
- STNE N/A
- ARWR N/A
- Revenue Growth
- STNE 24.14
- ARWR 2816.20
- 52 Week Low
- STNE $7.72
- ARWR $9.57
- 52 Week High
- STNE $19.95
- ARWR $43.69
- Technical
- Relative Strength Index (RSI)
- STNE 33.47
- ARWR 56.52
- Support Level
- STNE $16.54
- ARWR $39.33
- Resistance Level
- STNE $18.38
- ARWR $41.79
- Average True Range (ATR)
- STNE 0.68
- ARWR 2.47
- MACD
- STNE -0.31
- ARWR -0.27
- Stochastic Oscillator
- STNE 4.66
- ARWR 48.90
About STNE StoneCo Ltd.
StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.